Pacira BioSciences, Inc.
PCRX
$24.04
-$0.03-0.13%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 246.33M | 445.86M | 493.63M | 484.62M | 453.81M |
| Total Receivables | 115.47M | 114.77M | 105.15M | 113.80M | 100.95M |
| Inventory | 157.68M | 148.16M | 133.75M | 125.28M | 111.87M |
| Prepaid Expenses | 43.27M | 36.82M | 27.44M | 20.43M | 23.34M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 1.00M | -- |
| Total Current Assets | 562.75M | 745.61M | 759.96M | 745.13M | 689.97M |
|
|
|||||
| Total Current Assets | 562.75M | 745.61M | 759.96M | 745.13M | 689.97M |
| Net Property, Plant & Equipment | 191.65M | 201.71M | 213.18M | 216.39M | 220.68M |
| Long-term Investments | 20.32M | 20.30M | 21.52M | -- | -- |
| Goodwill | 20.32M | 20.30M | 21.52M | -- | -- |
| Total Other Intangibles | 382.40M | 422.56M | 434.97M | 425.97M | 440.29M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 120.19M | 128.27M | 129.01M | 136.58M | 134.02M |
| Total Assets | 1.30B | 1.54B | 1.59B | 1.55B | 1.52B |
|
|
|||||
| Total Accounts Payable | 17.69M | 30.12M | 23.17M | 19.13M | 19.37M |
| Total Accrued Expenses | 79.64M | 71.02M | 80.07M | 69.52M | 76.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.75M | 212.02M | 211.49M | 210.66M | 210.66M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 10.61M | -- |
| Total Other Current Liabilities | -- | -- | -- | 10.61M | -- |
| Total Current Liabilities | 107.08M | 313.16M | 314.73M | 309.92M | 306.40M |
|
|
|||||
| Total Current Liabilities | 107.08M | 313.16M | 314.73M | 309.92M | 306.40M |
| Long-Term Debt | 376.72M | 378.10M | 381.29M | 383.55M | 385.89M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 38.84M | 41.29M | 43.68M | 44.65M | 47.88M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 47.73M | 46.95M | 48.43M | 37.06M | 31.94M |
| Total Liabilities | 570.36M | 779.50M | 788.13M | 775.17M | 772.11M |
|
|
|||||
| Common Stock & APIC | 1.05B | 1.04B | 1.02B | 1.01B | 996.42M |
| Retained Earnings | -200.96M | -206.39M | -201.54M | -206.36M | -222.40M |
| Treasury Stock & Other | -121.42M | -71.45M | -23.77M | -24.78M | -24.44M |
| Total Common Equity | 727.21M | 757.77M | 798.54M | 778.35M | 749.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 727.21M | 757.77M | 798.54M | 778.35M | 749.58M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 727.21M | 757.77M | 798.54M | 778.35M | 749.58M |
|
|
|||||